HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -20.82 Million USD | -16.86% |
| 2021 | -17.82 Million USD | 9.0% |
| 2020 | -19.58 Million USD | -3.3% |
| 2019 | -18.96 Million USD | -17.33% |
| 2018 | -16.15 Million USD | 8.82% |
| 2017 | -17.72 Million USD | 27.16% |
| 2016 | -24.33 Million USD | -28.8% |
| 2015 | -18.89 Million USD | -47.02% |
| 2014 | -12.84 Million USD | -7.83% |
| 2013 | -11.91 Million USD | -12.96% |
| 2012 | -10.54 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 100.0% |
| 2023 Q1 | -5.01 Million USD | -10.15% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | -4.55 Million USD | -4.66% |
| 2022 Q2 | -5.67 Million USD | 9.23% |
| 2022 Q1 | -6.25 Million USD | -26.87% |
| 2022 Q3 | -4.34 Million USD | 23.41% |
| 2022 FY | -20.82 Million USD | -16.86% |
| 2021 Q2 | -4.08 Million USD | 10.91% |
| 2021 Q3 | -4.23 Million USD | -3.64% |
| 2021 FY | -17.82 Million USD | 9.0% |
| 2021 Q4 | -4.92 Million USD | -16.53% |
| 2021 Q1 | -4.58 Million USD | -13.89% |
| 2020 Q4 | -4.02 Million USD | 22.21% |
| 2020 Q3 | -5.17 Million USD | -3.44% |
| 2020 Q2 | -4.99 Million USD | 7.27% |
| 2020 Q1 | -5.39 Million USD | -24.96% |
| 2020 FY | -19.58 Million USD | -3.3% |
| 2019 FY | -18.96 Million USD | -17.33% |
| 2019 Q4 | -4.31 Million USD | 6.63% |
| 2019 Q3 | -4.62 Million USD | 1.82% |
| 2019 Q2 | -4.7 Million USD | 11.51% |
| 2019 Q1 | -5.31 Million USD | -157.5% |
| 2018 FY | -16.15 Million USD | 8.82% |
| 2018 Q4 | -2.06 Million USD | 57.01% |
| 2018 Q1 | -5.22 Million USD | -210.64% |
| 2018 Q2 | -4.06 Million USD | 22.23% |
| 2018 Q3 | -4.8 Million USD | -18.24% |
| 2017 Q4 | -1.68 Million USD | 67.03% |
| 2017 FY | -17.72 Million USD | 27.16% |
| 2017 Q1 | -5.42 Million USD | -3.52% |
| 2017 Q2 | -5.5 Million USD | -1.45% |
| 2017 Q3 | -5.1 Million USD | 7.37% |
| 2016 Q3 | -6.05 Million USD | 4.76% |
| 2016 Q2 | -6.36 Million USD | 4.57% |
| 2016 Q1 | -6.66 Million USD | -24.76% |
| 2016 FY | -24.33 Million USD | -28.8% |
| 2016 Q4 | -5.24 Million USD | 13.43% |
| 2015 FY | -18.89 Million USD | -47.02% |
| 2015 Q1 | -3.99 Million USD | -18.1% |
| 2015 Q4 | -5.34 Million USD | -10.74% |
| 2015 Q3 | -4.82 Million USD | -2.14% |
| 2015 Q2 | -4.72 Million USD | -18.17% |
| 2014 FY | -12.84 Million USD | -7.83% |
| 2014 Q3 | -3.13 Million USD | 12.27% |
| 2014 Q2 | -3.57 Million USD | -30.03% |
| 2014 Q1 | -2.75 Million USD | -4.83% |
| 2014 Q4 | -3.38 Million USD | -7.9% |
| 2013 Q4 | -2.62 Million USD | 2.39% |
| 2013 FY | -11.91 Million USD | -12.96% |
| 2013 Q2 | -3.3 Million USD | 0.0% |
| 2013 Q3 | -2.68 Million USD | 18.6% |
| 2012 FY | -10.54 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -1577.101% |
| Arrayit Corporation | -3.62 Million USD | -475.003% |
| Atlantic International Corp. | -5.73 Million USD | -263.359% |
| Biocept, Inc. | -31.98 Million USD | 34.873% |
| Bioqual, Inc. | -19.63 Thousand USD | -105967.807% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -2597.638% |
| DermTech, Inc. | -103.73 Million USD | 79.921% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.838% |
| iMD Companies, Inc. | -175.44 Thousand USD | -11772.369% |
| IDenta Corp. | -1499.00 USD | -1389466.111% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 842.853% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 53937.157% |
| InVitro International | -25.33 Thousand USD | -82103.702% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -192.468% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -35743.881% |
| Medical Imaging Corp. | -819.48 Thousand USD | -2441.807% |
| NovelStem International Corp. | -3.52 Million USD | -490.777% |
| Optigenex Inc. | 1.39 Million USD | 1597.632% |
| PharmChem, Inc. | 973.14 Thousand USD | 2240.437% |
| Proteome Sciences plc | -1.62 Million USD | -1184.984% |
| Response Genetics, Inc | -21.37 Million USD | 2.561% |
| Rennova Health, Inc. | -1.4 Million USD | -1377.765% |
| RushNet, Inc. | -684.7 Thousand USD | -2942.127% |
| ScreenPro Security Inc. | -2.59 Million USD | -703.478% |
| Stella Diagnostics Inc. | -11.42 Million USD | -82.285% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -168.881% |
| Todos Medical Ltd. | -9.74 Million USD | -113.681% |